Article
Sustained high proportion of zidovudine-resistant HIV variants despite prolonged substitution of zidovudine by other nucleoside reverse transcriptase inhibitors.
Journal of medical virology - 1 Sept 2002
Bélec Laurent, Legoff Jérôme, Si-Mohamed Ali, Andréoletti Laurent, Mbopi-Kéou François-Xavier, Kolberg Janice, Matta Mathieu, Detmer Jill, Piketty Christophe, Kazatchkine Michel D
Abstract excerpt
The consequences of zidovudine (ZDV) replacement by other nucleoside reverse transcriptase inhibitors on the expression of resistance mutations at codons 215 and 41 of the reverse transcriptase (RT) gene was investigated prospectively in 66 patients harboring mutant genotypes who were changed to an effective two- or three-drug combination antiretroviral regimen. Quantitation of mutant (MUT) viral populations at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
